Nissan now recalls 540,000 cars

The auto sector continues to struggle with new recalls from Nissan

A new batch of vehicle recalls were announced early today by Japanese carmaker Nissan, as the industry struggles with record recalls due to component failures.

Nissan said it is recalling more than 540,000 vehicles mainly for two problems. First, on select models, the fuel gauge displays inaccurate fuel levels, indicating the car is plenty of fuel when it is almost empty.

The second problem, and potentially a more serious problem, that Nissan has identified is related to braking pedal pins that come lose in turn not allowing the drive to slow the car down. The affected models with the brake issue include the 2008-2010 Nissan Titan, Infiniti QX56 (also affected with the fuel gauge issue), Nissan Armada, and the Nissan Quest.

Nissan says there have been no reports of any accidents as a result of these component failures. The company will be contacting owners via mail to schedule a fix at a local dealership.

The following Nissan vehicles are affected with the fuel gauge problem: Nissan Frontiers, 2005-2008 Titan, Pathfinder, Infiniti QX56, and 2006-2008 Nissan Xterras. The company says UK consumers should not be affected by any of the recalls.

Last month, Nissan experienced a higher than expected increase in sales over the same period last year, while significantly gaining more market share from competitors. The latest recalls could spur a decline in consumer confidence despite the good reputation the company has when it comes to reliability.

Less than a day ago, General Motors recalled up to 1.3-million of its vehicles mainly relating to steering issues.

The most serious of the recent vehicle recalls started last January when Toyota recalled more than 1.3 million of its vehicles for braking failure and unintended sudden acceleration. Those issues claimed the lives of dozens.

Total U.S. sales in February 2010 for Toyota dropped by 9-percent.


tag TAGS: , , ,
Short URL: http://business2press.com?p=5093
Recommended:
b2p Ensure that you follow us on Twitter and Like us on Facebook
Ramy holds a Bachelor in Health Studies with honors in Health Management from York University in Toronto, Canada. He just returned to Toronto following a career opportunity teaching English in South Korea. Write to ramy@business2press.com
checkmark
We are perfectly committed to the highest ethical and professional codes of conduct and standards in the industry on a firm wide basis. Learn more about us, our contributors, and our governance
b2p
We encourage you to comment. Comments are moderated. Comments that are abusive, off-topic, have marginal substance, or include promotional content will be removed. We cannot facilitate requests to edit or remove comments, or explain moderation decisions

Business 2.0 Press publishes exclusive business tech news and analysis covering start-ups to large-caps from Bay & Wall streets since 2008 from a group of highly knowledgeable industry professionals that abide by the toughest industry codes of conduct and professional standards lightMore

lightAdd value by subscribing (RSS)

logo

StockFractions.com has the most stock ratios for public companies. Get the most comprehensive micro insight on public firms available on the web, all for free.
Stock Fractionsgo

title

Colon cancer is one of the leading causes of death. Irrespective of family history, everyone is exposed to the risk. About 90% of colon cancer cases begin from non-cancerous tumors, polyps, which could form in the large bowel. Screening with a colonoscopy will painlessly remove any polyps hence almost entirely reducing your risk of developing the horrible disease. The good news is that about 90% of colon cancer cases are preventable through a simple (yes, simple) colonoscopy.
Learn moreatom
Public service message from Business 2.0 Press